Overview

FOLFIRI as Salvage Treatment in Metastatic Biliary Tract Cancer (BTC) Patients Who Were Failed After Gemcitabine Containing Chemotherapy: A Phase II Single Arm Prospective Study

Status:
Not yet recruiting
Trial end date:
2021-12-01
Target enrollment:
Participant gender:
Summary
FOLFIRI as a salvage treatment in metastatic biliary tract cancer (BTC) patients who failed gemcitabine containing chemotherapy
Phase:
Phase 2
Details
Lead Sponsor:
Samsung Medical Center
Treatments:
Calcium
Fluorouracil
Irinotecan
Leucovorin
Levoleucovorin